Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 250408, 6 pages
http://dx.doi.org/10.1155/2014/250408
Research Article

Misidentification of Candida guilliermondii as C. famata among Strains Isolated from Blood Cultures by the VITEK 2 System

1Department of Laboratory Medicine, Inje University College of Medicine, Busan 614-735, Republic of Korea
2Paik Institute for Clinical Research, Inje University College of Medicine, Busan 614-735, Republic of Korea
3Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Republic of Korea
4Biomedical Research Institute, Pusan National University School of Medicine, Busan 602-739, Republic of Korea
5Department of Laboratory Medicine, Pusan National University School of Medicine, Busan 602-739, Republic of Korea
6Department of Oral Biochemistry, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea
7Korean Collection for Type Cultures, Biological Resource Center, KRIBB, Daejeon 305-806, Republic of Korea
8Department of Dental Hygiene, College of Medical and Life Science, Silla University, Busan 617-736, Republic of Korea
9Department of Internal Medicine, Pusan National University Hospital, 179, Gudeok-ro, Seo-gu, Busan 602-739, Republic of Korea

Received 28 February 2014; Revised 21 April 2014; Accepted 21 April 2014; Published 29 May 2014

Academic Editor: Mina Hur

Copyright © 2014 Si Hyun Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Wenzel, “Nosocomial candidemia: risk factors and attributable mortality,” Clinical Infectious Diseases, vol. 20, no. 6, pp. 1531–1534, 1995. View at Google Scholar · View at Scopus
  2. E. J. Won, J. H. Shin, W. K. Lee et al., “Distribution of yeast and mold species isolated from clinical specimens at 12 hospitals in Korea during 2011,” Annals of Clinical Microbiology, vol. 16, no. 2, pp. 92–100, 2013. View at Publisher · View at Google Scholar
  3. P. E. Verweij, I. M. Breuker, A. J. M. M. Rijs, and J. F. G. M. Meis, “Comparative study of seven commercial yeast identification systems,” Journal of Clinical Pathology, vol. 52, no. 4, pp. 271–273, 1999. View at Google Scholar · View at Scopus
  4. D. Wagner, A. Sander, H. Bertz, J. Finke, and W. V. Kern, “Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis,” Infection, vol. 33, no. 5-6, pp. 397–400, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Barnett, R. W. payne, and D. Yarrow, Yeasts: characteristics and Identification, Cambridge University Press, Cambridge, UK, 3rd edition, 2000.
  6. A. J. Gupta, H. Mi, C. Wroe, B. Jaques, and D. Talbot, “Fatal Candida famata peritonitis complicating sclerosing peritonitis in a peritoneal dialysis patient,” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 2036–2037, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. St.-Germain and M. Laverdiere, “Torulopsis candida, a new opportunistic pathogen,” Journal of Clinical Microbiology, vol. 24, no. 5, pp. 884–885, 1986. View at Google Scholar · View at Scopus
  8. A. Nishikawa, T. Sugita, and T. Shinoda, “Differentiation between Debaryomyces hansenii/Candida famata complex and Candida guilliermondii by polymerase chain reaction,” FEMS Immunology and Medical Microbiology, vol. 19, no. 2, pp. 125–129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Desnos-Ollivier, M. Ragon, V. Robert, D. Raoux, J.-C. Gantier, and F. Dromer, “Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii),” Journal of Clinical Microbiology, vol. 46, no. 10, pp. 3237–3242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Xu, B. C. Millar, J. E. Moore et al., “Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections,” Journal of Clinical Pathology, vol. 55, no. 10, pp. 774–777, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Edmond, S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel, “Nosocomial bloodstream infections in United States hospitals: a three-year analysis,” Clinical Infectious Diseases, vol. 29, no. 2, pp. 239–244, 1999. View at Google Scholar · View at Scopus
  12. M.-K. Lee, D. Yong, M. Kim, M.-N. Kim, and K. Lee, “Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007,” Korean Journal of Laboratory Medicine, vol. 30, no. 4, pp. 364–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Nishikawa, H. Tomomatsu, T. Sugita, R. Ikeda, and T. Shinoda, “Taxonomic position of clinical isolates of Candida famata,” Journal of Medical and Veterinary Mycology, vol. 34, no. 6, pp. 411–419, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. F. Ngeow and T. S. Soo-Hoo, “Incidence and distribution of vaginal yeasts in Malaysian women,” Mycoses, vol. 32, no. 11, pp. 563–567, 1989. View at Google Scholar · View at Scopus
  15. N. A. Rao, A. V. Nerenberg, and D. J. Forster, “Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome,” Archives of Ophthalmology, vol. 109, no. 12, pp. 1718–1721, 1991. View at Google Scholar · View at Scopus
  16. G. Quindos, F. Cabrera, M. D. C. Arilla et al., “Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole,” Clinical Infectious Diseases, vol. 18, no. 4, pp. 658–660, 1994. View at Google Scholar · View at Scopus
  17. J. Renneberg, K. Rieneck, and E. Gutschik, “Evaluation of Staph ID 32 system and Staph-Zym system for identification of coagulase-negative staphylococci,” Journal of Clinical Microbiology, vol. 33, no. 5, pp. 1150–1153, 1995. View at Google Scholar · View at Scopus
  18. M. J. Burton, P. Shah, and E. Swiatlo, “Misidentification of candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis,” American Journal of the Medical Sciences, vol. 341, no. 1, pp. 71–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Huh, J. H. Lee, K. S. Park et al., “A case of misidentification of Aspergillus versicolor complex as Scopulariopsis species isolated from a homograft,” Annals of Clinical Microbiology, vol. 16, no. 2, pp. 105–109, 2013. View at Publisher · View at Google Scholar
  20. S. H. Kim, H. S. Jeong, Y. H. Kim et al., “Evaluation of DNA extraction methods and their clinical application for direct detection of causative bacteria in continuous ambulatory peritoneal dialysis culture fluids from patients with peritonitis by using broad-range PCR,” Annals of Laboratory Medicine, vol. 32, no. 2, pp. 119–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kim, M. J. Kwon, H.-S. Chung et al., “Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of aerobic bacteria in a clinical microbiology laboratory,” Korean Journal of Clinical Microbiology., vol. 15, no. 2, pp. 60–66, 2012. View at Publisher · View at Google Scholar
  22. M. Sanguinetti, R. Porta, M. Sali et al., “Evaluation of VITEK 2 and RapID Yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory,” Journal of Clinical Microbiology, vol. 45, no. 4, pp. 1343–1346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Valenza, J. Strasen, F. Schäfer, M. Frosch, O. Kurzai, and M. Abele-Horn, “Evaluation of new colorimetric Vitek 2 yeast identification card by use of different source media,” Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3784–3787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. C. Iwen, A. G. Freifeld, T. A. Bruening, and S. H. Hinrichs, “Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system,” Journal of Clinical Microbiology, vol. 42, no. 5, pp. 2292–2293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. T. J. Lott, R. J. Kuykendall, and E. Reiss, “Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species,” Yeast, vol. 9, no. 11, pp. 1199–1206, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-H. Jang, J. H. Lee, C.-S. Ki, and N. Y. Lee, “Identification of clinical mold isolates by sequence analysis of the internal transcribed spacer region, ribosomal large-subunit D1/D2, and β-tubulin,” Annals of Laboratory Medicine, vol. 32, no. 2, pp. 126–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bizzini and G. Greub, “Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification,” Clinical Microbiology and Infection, vol. 16, no. 11, pp. 1614–1619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. G. Stevenson, S. K. Drake, Y. R. Shea, A. M. Zelazny, and P. R. Murray, “Evaluation of matrix-assisted laser desorption ionization—time of flight mass spectrometry for identification of clinically important yeast species,” Journal of Clinical Microbiology, vol. 48, no. 10, pp. 3482–3486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Lacroix, A. Gicquel, B. Sendid et al., “Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species,” Clinical Microbiology and Infection, vol. 20, pp. 153–158, 2013. View at Publisher · View at Google Scholar · View at Scopus